CAY10498 (2-phenyl-amino-N6-endo-norbornyladenine) is utilized in scientific research as a selective inhibitor of adenosine kinase (AK), an enzyme critical to adenosine metabolism. By inhibiting AK, CAY10498 aids in studies on ischemia and inflammation, as adenosine regulates blood flow and inflammatory responses.

Additionally, CAY10498 is employed to evaluate drug efficacy in treating neurological disorders, such as epilepsy and central nervous system conditions. These investigations aim to develop more effective and safer therapeutic approaches.